No Data
No Data
No Data
No Data
No Data
Express News | Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Moomoo 24/7Apr 19 16:05 ET
Trade Alert: President Of Soleno Therapeutics Anish Bhatnagar Has Sold Stock
We wouldn't blame Soleno Therapeutics, Inc. (NASDAQ:SLNO) shareholders if they were a little worried about the fact that Anish Bhatnagar, the President recently netted about US$785k selling shares at
Simply Wall StApr 10 14:33 ET
Soleno Therapeutics Insider Sold Shares Worth $784,645, According to a Recent SEC Filing
Bhatnagar Anish, Director, CHIEF EXECUTIVE OFFICER, on April 01, 2024, sold 18,980 shares in Soleno Therapeutics (SLNO) for $784,645. Following the Form 4 filing with the SEC, Anish has control over a
MT NewswiresApr 4 07:24 ET
Insider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)
Yahoo FinanceApr 4 01:54 ET
Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Biomea Fusion (BMEA) and Soleno Therapeutics (SLNO)
TipRanksMar 22 07:20 ET
Analysts' Top Healthcare Picks: Soleno Therapeutics (SLNO), Optinose (OPTN)
TipRanksMar 18 07:00 ET
No Data
No Data